Read + Share
Amedeo Smart
Independent Medical Education
Manzano RG, Catalan-Latorre A, Brugarolas A. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer. BMC Cancer 2021;21:432.PMID: 33879103
Email
LinkedIn
Facebook
Twitter
Privacy Policy